Cargando…
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
The challenges to effective drug delivery to brain tumors are twofold: (1) there is a lack of non-invasive methods of local delivery and (2) the blood-brain barrier limits systemic delivery. Intranasal delivery of therapeutics to the brain overcomes both challenges. In mouse model of malignant gliom...
Autores principales: | Dey, Mahua, Yu, Dou, Kanojia, Deepak, Li, Gina, Sukhanova, Madina, Spencer, Drew A., Pituch, Katatzyna C., Zhang, Lingjiao, Han, Yu, Ahmed, Atique U., Aboody, Karen S., Lesniak, Maciej S., Balyasnikova, Irina V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032402/ https://www.ncbi.nlm.nih.gov/pubmed/27594591 http://dx.doi.org/10.1016/j.stemcr.2016.07.024 |
Ejemplares similares
-
Immune System, Friend or Foe of Oncolytic Virotherapy?
por: Filley, Anna C., et al.
Publicado: (2017) -
Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
por: Auffinger, Brenda, et al.
Publicado: (2013) -
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: Targeted delivery of the therapeutic payload in an orthotopic brain tumor model
por: Thaci, Bart, et al.
Publicado: (2012) -
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions
por: Kim, Janice, et al.
Publicado: (2015) -
The use of anti-GITR antibody treatment in a murine model of glioblastoma multiforme
por: Miska, Jason, et al.
Publicado: (2015)